Omeros - 16 Year Stock Price History | OMER

Historical daily share price chart and data for Omeros since 2009 adjusted for splits and dividends. The latest closing stock price for Omeros as of July 29, 2025 is 3.97.
  • The all-time high Omeros stock closing price was 26.69 on September 04, 2018.
  • The Omeros 52-week high stock price is 13.60, which is 242.6% above the current share price.
  • The Omeros 52-week low stock price is 2.95, which is 25.7% below the current share price.
  • The average Omeros stock price for the last 52 weeks is 6.12.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Omeros Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 6.4016 9.8400 11.2100 2.9700 3.9700 -59.82%
2024 4.6401 3.2900 12.1500 2.8800 9.8800 202.14%
2023 3.8862 2.4800 7.5700 1.0800 3.2700 44.69%
2022 4.2523 6.9900 7.4600 1.7500 2.2600 -64.85%
2021 14.5458 14.5200 23.5300 5.6700 6.4300 -54.99%
2020 13.3243 13.6150 21.3200 9.0300 14.2850 1.38%
2019 16.0534 11.8500 20.5600 11.6500 14.0900 26.48%
2018 16.9450 20.1550 26.6900 9.0000 11.1400 -42.67%
2017 17.1065 10.1000 26.5800 8.9500 19.4300 95.87%
2016 11.5152 14.7900 16.3700 7.3400 9.9200 -36.94%
2015 18.3820 25.0100 26.3500 10.9000 15.7300 -36.52%
2014 14.3080 12.0600 24.7800 9.9400 24.7800 119.49%
2013 6.4532 5.3900 13.2300 3.7600 11.2900 117.53%
2012 8.6929 4.0000 13.2500 3.9900 5.1900 31.39%
2011 4.8167 8.5000 8.5000 3.1700 3.9500 -52.06%
2010 6.8037 7.2900 8.7700 5.2400 8.2400 17.38%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.256B $0.000B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $219.828B 25.79
Boston Scientific (BSX) United States $156.585B 37.40
Stryker (SYK) United States $152.939B 31.98
EssilorLuxottica (ESLOY) France $137.925B 0.00
Medtronic (MDT) Ireland $117.956B 16.72
Lonza Group Ag (LZAGY) Switzerland $49.343B 0.00
Haleon (HLN) United Kingdom $43.576B 24.87
ResMed (RMD) United States $40.103B 30.12
GE HealthCare Technologies (GEHC) United States $35.596B 16.90
Agilent Technologies (A) United States $33.957B 22.14
Terumo (TRUMY) Japan $25.643B 33.31
Koninklijke Philips (PHG) Netherlands $24.709B 17.34
Insulet (PODD) United States $20.568B 80.74
Zimmer Biomet Holdings (ZBH) United States $18.989B 12.20
Baxter (BAX) United States $14.636B 10.93
Smith & Nephew SNATS (SNN) United Kingdom $13.656B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.891B 23.98
Lantheus Holdings (LNTH) United States $5.010B 12.64
Perrigo (PRGO) Ireland $3.867B 9.80
Prestige Consumer Healthcare (PBH) United States $3.770B 16.84
Haemonetics (HAE) United States $3.587B 16.34
Envista Holdings (NVST) United States $3.515B 29.21
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.138B 23.14
LeMaitre Vascular (LMAT) United States $1.863B 41.65
QuidelOrtho (QDEL) United States $1.764B 12.14
AtriCure (ATRC) United States $1.645B 0.00
Acuren (TIC) United States $1.367B 0.00
Green Thumb Industries (GTBIF) United States $1.332B 29.96
AdaptHealth (AHCO) United States $1.294B 13.14
Neogen (NEOG) United States $1.176B 15.06
Phibro Animal Health (PAHC) United States $1.172B 14.98
BioLife Solutions (BLFS) United States $1.063B 0.00
Curaleaf Holdings (CURLF) Canada $0.987B 0.00
InMode (INMD) Israel $0.919B 9.26
Kestra Medical Technologies (KMTS) United States $0.847B 0.00
Tilray Brands (TLRY) Canada $0.704B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.675B 0.00
Valneva SE (VALN) France $0.648B 0.00
Owens & Minor (OMI) United States $0.608B 5.04
Evolus (EOLS) United States $0.598B 0.00
CeriBell (CBLL) United States $0.541B 0.00
Surmodics (SRDX) United States $0.524B 0.00
ZimVie (ZIMV) United States $0.524B 23.82
SNDL (SNDL) Canada $0.394B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.358B 0.00
Cresco Labs (CRLBF) United States $0.329B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.97
Quanterix (QTRX) United States $0.324B 0.00
Capricor Therapeutics (CAPR) United States $0.310B 0.00
Sanuwave Health (SNWV) United States $0.306B 0.00
Aurora Cannabis (ACB) Canada $0.269B 79.67
Cerus (CERS) United States $0.260B 0.00
OraSure Technologies (OSUR) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.246B 20.77
Biote (BTMD) United States $0.239B 6.72
Verano Holdings (VRNOF) United States $0.238B 0.00
Brainsway (BWAY) Israel $0.227B 60.00
Canopy Growth (CGC) Canada $0.224B 0.00
Sanara MedTech (SMTI) United States $0.222B 0.00
Organigram Global (OGI) Canada $0.198B 0.00
Utah Medical Products (UTMD) United States $0.188B 15.45
High Tide (HITI) Canada $0.184B 0.00
TriSalus Life Sciences (TLSI) United States $0.172B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Exagen (XGN) United States $0.157B 0.00
TerrAscend (TSNDF) Canada $0.138B 0.00
FitLife Brands (FTLF) United States $0.120B 14.83
MacroGenics (MGNX) United States $0.105B 0.00
Jushi Holdings (JUSHF) United States $0.104B 0.00
Jin Medical (ZJYL) China $0.104B 0.00
Fonar (FONR) United States $0.099B 12.77
Quipt Home Medical (QIPT) United States $0.093B 0.00
Apyx Medical (APYX) United States $0.091B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Safety Shot (SHOT) United States $0.088B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Veru (VERU) United States $0.077B 0.00
InterCure (INCR) Israel $0.069B 0.00
Agape ATP (ATPC) $0.067B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
United-Guardian (UG) United States $0.039B 13.38
Nephros (NEPH) United States $0.038B 51.43
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Senestech (SNES) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00